Shawn Patrick Zinnen
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$3.0MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $3.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 12, 2018 | NIH | SBIR Phase II Novel Bone-Targeting Combination Therapy for Osteosarcoma Phase II | $137K | MBC PHARMA, INC. |
| Sep 11, 2018 | NIH | SBIR Phase II Novel Bone-Targeting Combination Therapy for Osteosarcoma Phase II | $860K | MBC PHARMA, INC. |
| Jul 19, 2018 | NIH | SBIR Phase I Bone Targeted Antibiotics | $294K | MBC PHARMA, INC. |
| Sep 12, 2017 | NIH | SBIR Phase II Novel Bone-Targeting Combination Therapy for Osteosarcoma Phase II | $1.1M | MBC PHARMA, INC. |
| Aug 7, 2017 | NIH | SBIR Phase I Bone Targeted Antibiotics | $300K | MBC PHARMA, INC. |
| Jan 15, 2016 | NIH | SBIR Phase I Novel Bone-Targeting Combination Therapy for Osteosarcoma | $302K | MBC PHARMA, INC. |
Peer ranks
Federal funding#592
Awards as PI#315
Patents#273
Companies
- MBC PHARMA, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.